Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
O
153710
vs
K
KOSPI 200
Over the past 12 months, OptiPharm Co Ltd has underperformed KOSPI 200, delivering a return of -10% compared to KOSPI 200's +125% growth.
Stocks Performance
153710 vs KOSPI 200
Performance Gap
153710 vs KOSPI 200
Performance By Year
153710 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
OptiPharm Co Ltd
Glance View
OptiPharm Co Ltd makes eye-care medicines and related medical products. Its core business is selling ophthalmic drugs such as eye drops and other sterile products used to treat dry eye, inflammation, and other common eye conditions. It also works as a manufacturer for other health-care brands, which means it can produce eye products under partner labels as well as its own. Its customers are mainly hospitals, clinics, pharmacies, and other drug distributors that need reliable eye medicines they can prescribe or resell. OptiPharm makes money by selling finished pharmaceutical products and, in some cases, by producing goods for other companies that want a contract manufacturer. That gives it a mix of branded sales and manufacturing revenue. What makes the business model distinctive is its narrow focus on the eye-care niche. Instead of trying to cover all kinds of medicines, OptiPharm concentrates on products that must be clean, stable, and carefully formulated for use around the eyes. That puts it in a specialized part of the drug supply chain where quality, regulatory compliance, and trusted manufacturing matter a lot.